Cyclerion Therapeutics, Inc.CYCNNASDAQ
Loading
Year-over-year free cash flow growth rate
| Period | Value |
|---|---|
| Q3 2025 | 47.51% |
| Q2 2025 | 48.04% |
| Q1 2025 | -368.89% |
| Q4 2024 | 120.98% |
| Q3 2024 | -55.15% |
| Q2 2024 | 40.89% |
| Q1 2024 | -21.41% |
| Q4 2023 | 77.78% |
| Q3 2023 | -5.80% |
| Q2 2023 | -5.49% |
| Q1 2023 | 11.77% |
| Q4 2022 | 28.97% |
| Q3 2022 | 8.35% |
| Q2 2022 | 15.71% |
| Q1 2022 | -48.73% |
| Q4 2021 | -8.83% |
| Q3 2021 | -43.95% |
| Q2 2021 | 61.89% |
| Q1 2021 | -2.69% |
| Q4 2020 | 6.52% |
| Q3 2020 | -5.32% |
| Q2 2020 | 53.26% |
| Q1 2020 | -36.93% |
| Q4 2019 | 8.70% |
| Q3 2019 | 6.68% |
| Q2 2019 | 27.35% |
| Q1 2019 | -44.52% |
| Q4 2018 | 5.65% |
| Q3 2018 | -15.47% |
| Q2 2018 | 13.81% |
| Q1 2018 | 0.00% |
| Q4 2017 | 0.00% |
| Q3 2017 | 0.00% |